Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 32Hodgkin Disease 29Lymphoma 10Sarcoma 7Uveal Melanoma 5Neoplasm Metastasis 4Neoplasms 3Leiomyosarcoma 2HIV Infections 2Solitary Fibrous Tumors 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Neuroblastoma 1Lymphoma, T-Cell, Peripheral 1Immunotherapy 1Hyperthermia 1Hematologic Diseases 1Carcinoma 1Advanced Melanoma 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Doxorubicin 4Gemcitabine 3pembrolizumab 2pazopanib 2fludarabine 2cixutumumab 2brostallicin 2Sorafenib 2Radiation Dose Hypofractionation 2Docetaxel 2Cyclophosphamide 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2tremelimumab 1tazemetostat 1sotigalimab 1soblidotin 1romidepsin 1reolysin 1perifosine 1pasireotide 1lorvotuzumab mertansine 1ixabepilone 1interferon gamma-1b 1exatecan 1durvalumab 1drozitumab 1atezolizumab 1Trastuzumab 1Trabectedin 1Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma, Synovial × Dacarbazine × Clear all
NCT00837148 2015-11-20

Sorafenib and Dacarbazine in Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
37 enrolled 6 charts
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡